Literature DB >> 15920135

Angiotensin receptor blockers and myocardial infarction: cautions voiced are biologically credible.

Zaheer R Yousef, Francisco Leyva, Christopher Gibbs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920135      PMCID: PMC558134          DOI: 10.1136/bmj.330.7502.1270-a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system.

Authors:  Bernard I Lévy
Journal:  Circulation       Date:  2004-01-06       Impact factor: 29.690

2.  Angiotensin receptor blockers and myocardial infarction.

Authors:  Subodh Verma; Marty Strauss
Journal:  BMJ       Date:  2004-11-27

3.  Plasma angiotensins and blood pressure during converting enzyme inhibition.

Authors:  P F Mento; B M Wilkes
Journal:  Hypertension       Date:  1987-06       Impact factor: 10.190

4.  Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.

Authors:  S Yusuf; C J Pepine; C Garces; H Pouleur; D Salem; J Kostis; C Benedict; M Rousseau; M Bourassa; B Pitt
Journal:  Lancet       Date:  1992-11-14       Impact factor: 79.321

Review 5.  Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

Authors:  W Linz; G Wiemer; P Gohlke; T Unger; B A Schölkens
Journal:  Pharmacol Rev       Date:  1995-03       Impact factor: 25.468

  5 in total
  1 in total

Review 1.  A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors.

Authors:  Helmy M Siragy
Journal:  Vasc Health Risk Manag       Date:  2011-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.